0001209191-21-026826.txt : 20210415
0001209191-21-026826.hdr.sgml : 20210415
20210415161655
ACCESSION NUMBER: 0001209191-21-026826
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210413
FILED AS OF DATE: 20210415
DATE AS OF CHANGE: 20210415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Donnell Niall
CENTRAL INDEX KEY: 0001780235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40315
FILM NUMBER: 21828676
MAIL ADDRESS:
STREET 1: C/O RIVERVEST VENTURE PARTNERS
STREET 2: 101 SOUTH HANLEY RD., STE 1850
CITY: ST. LOUIS
STATE: MO
ZIP: 63105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001637715
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472309515
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: P.O. BOX 675614
CITY: RANCHO SANTA FE
STATE: CA
ZIP: 92067
BUSINESS PHONE: 619-733-3852
MAIL ADDRESS:
STREET 1: P.O. BOX 675614
CITY: RANCHO SANTA FE
STATE: CA
ZIP: 92067
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-13
0
0001637715
Reneo Pharmaceuticals, Inc.
RPHM
0001780235
O'Donnell Niall
C/O RENEO PHARMACEUTICALS, INC.
12230 EL CAMINO REAL, SUITE 230
SAN DIEGO
CA
92130
1
0
0
0
Common Stock
2021-04-13
4
C
0
1034600
A
1034600
I
By RiverVest Venture Fund IV, L.P.
Common Stock
2021-04-13
4
C
0
829113
A
1863713
I
By RiverVest Venture Fund IV, L.P.
Common Stock
2021-04-13
4
P
0
200000
15.00
A
2063713
I
By RiverVest Venture Fund IV, L.P.
Series A Preferred Stock
2021-04-13
4
C
0
4629630
0.00
D
Common Stock
1034600
0
I
By RiverVest Venture Fund IV, L.P.
Series B Preferred Stock
2021-04-13
4
C
0
3710116
0.00
D
Common Stock
829113
0
I
By RiverVest Venture Fund IV, L.P.
All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 4.4748 shares of Preferred Stock. The Preferred Stock had no expiration date.
The shares held by RiverVest Venture Fund IV, L.P. ("RiverVest Fund IV") are indirectly held by RiverVest Venture Partners IV, L.P., its general partner ("RiverVest Partners IV"). RiverVest Venture Partners IV, LLC is the general partner of RiverVest Partners IV. The individual managers of RiverVest Ventures Partners IV, LLC are Jay Schmelter, John P. McKearn, Ph.D. and the Reporting Person. RiverVest Partners IV, RiverVest Venture Partners IV, LLC and each of the individual managers (including the Reporting Person) share voting and dispositive power with regard to the Company's securities directly held by RiverVest Fund IV.
The shares were purchased in the Issuer's initial public offering.
/s/ Vineet R. Jindal, Attorney-in-Fact
2021-04-15